Your Location:
Home >
Browse articles >
Gadd45a knockout alleviates cisplatin-induced hearing loss by inhibiting CXCL family protein expression- “A research team introduces its progress in preventing cisplatin-induced hearing loss. Researchers established the GADD45A-NF-κB1-CXCL signaling pathway through CRISPR-Cas9 screening, which provides solutions to solve chemotherapy ototoxicity problems.”
- Military Medical Research (2026)
DOI: 10.1016/j.mmr.2026.100063
Accepted:07 August 2026
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 7 ) Tabs( 0 )
References
Publication Info
Metrics
27
Views
10
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Ototoxicity of vancomycin in guinea pigs
Attenuation of cisplatin induced ototoxicity by sound preonditioning through NO pathway
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies
Related Author
No data
Related Institution
Department of Physiology
College of Basic Medical Sciences
Second Military Medical University
Department of PhysiologyCollege of Basic Medical Sciences Second Military Medical University

